abrdn Life Sciences Investors (NYSE:HQL)
$ 13.44 -0.03 (-0.22%) Market Cap: 367.59 Mil Enterprise Value: 367.59 Mil PE Ratio: 17.01 PB Ratio: 0.90 GF Score: 41/100

abrdn Life Sciences Investors (HQL) Transcripts

    • 1